Physiologic pacing for atrial fibrillation prevention in sinus node disease: Long-term results

PACE - Pacing and Clinical Electrophysiology

Volumn 29, Issue SUPPL. 2, 2006, Pages

  Ricci, Renato ^a,b   Pignalberi, Carlo ^a   Santini, Luca ^a   Magris, Barbara ^a   Russo, Maurizio ^a   Grovale, Nicoletta ^b   De Santo, Tiziana ^b   Santini, Massimo ^a  

^a SAN FILIPPO NERI HOSPITAL   (Italy)

^b Medtronic ^*  (Italy)

Author keywords

Arrhythmia risk factors; Atrial fibrillation; Cardiac pacing; Pacing modality; Physiologic pacing; Sinus node disease

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; SOTALOL;

ADULT; AGED; ARTICLE; CARDIOVERSION; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART MUSCLE CONDUCTION DISTURBANCE; HEART PACING; HUMAN; IMPLANTATION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PREDICTION; RECURRENT DISEASE; RETROSPECTIVE STUDY; SINUS NODE DISEASE; SURVIVAL; VALVULAR HEART DISEASE;

AGED; ARRHYTHMIA, SINUS; ATRIAL FIBRILLATION; CARDIAC PACING, ARTIFICIAL; COMORBIDITY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; ITALY; LONGITUDINAL STUDIES; MALE; PREVALENCE; RECURRENCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS;

EID: 33751372918     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2006.00494.x     Document Type: Article

References (42)

1. Sutton R, Kenny RA. The natural history of sick sinus syndrome. Pacing Clin Electrophysiol 1986; 9:1110-1114.
2. Camm AJ, Katritsis D. Ventricular pacing for sick sinus syndrome: A risky business? Pacing Clin Electrophysiol 1990; 13:695-699.
3. Santini M, Alexidou G, Ansalone G, Cacciatore G, Cini R, Turitto G. Relation of prognosis in sick sinus syndrome to age, conduction defects and modes of permanent cardiac pacing. Am J Cardiol 1990; 65:729-735.
4. Stangl K, Seitz K, Wirtzfeld A, Alt E, Blommer H. Differences between atrial single chamber pacing (AAI) and ventricular single chamber pacing (VVI) with respect to prognosis and antiarrhythmic effect in patients with sick sinus syndrome. Pacing Clin Electrophysiol 1990; 13:2080-2085.
5. Feuer JM, Shandling AH, Messenger JC. Influence of cardiac pacing mode on the long-term development of atrial fibrillation. Am J Cardiol 1989; 64:1376-1379.
6. Rosenqvist M, Brandt J, Schuller H. Long-term pacing in sinus node disease: Effects of stimulation mode on cardiovascular morbidity and mortality. Am. Heart J 1988; 116:16-22.
7. Hesselson AB, Parsonnet V, Bernstein AD, Bonavita GJ. Deleterious effects of long-term single-chamber ventricular pacing in patients with sick sinus syndrome: The hidden benefits of dual-chamber pacing. J Am Coll Cardiol 1992; 19:1542-1549.
8. Sgarbossa EB, Pinski SL, Maloney JD, Simmons TW, Wilkoff BL, Castle LW, Trohman RG. Chronic atrial fibrillation and stroke in paced patients with sick sinus syndrome. Relevance of clinical characteristics and pacing modalities. Circulation 1993; 88:1045-1053.
9. Santini M, Ricci R, Puglisi A, Mangiameli S, Proclemer A, Menozzi C, De Fabrizio G, et al. Long-term haemodynamic and antiarrhythmic benefits of DDIR versus DDI pacing mode in sick sinus syndrome and chronotropic incompetence. G. Ital Cardiol 1997; 27:892-900.
10. Andersen HR, Nielsen JC, Thomsen PEB, Thuesen L, Mortensen PT, Vesterlund T, Pedersen AK. Long-term follow up of patients from a randomised trial of atrial versus ventricular pacing for sicksinus syndrome. Lancet 1997; 350:1210-1216.
11. Mattioli AV, Vivoli D, Mattioli G. Influence of pacing modalities on the incidence of atrial fibrillation in patients without prior atrial fibrillation: A prospective study. Eur Heart J 1998; 19:282-286.
12. Skanes AC, Krahn AD, Yee R, Klein GJ, Connolly SJ, Kerr CR, Gent M, et al. for the CTOPP Investigators. Progression to chronic atrial fibrillation after pacing: The Canadian Trial of Physiologic Pacing. J Am Coll Cardiol 2001; 38:167-172.
13. Lamas GA, Lee KL, Sweeney MO, Silverman R, Leon A, Yee R, Marinchak RA, et al. for the Mode Selection Trial in sinus node dysfunction. Ventricular pacing or dual chamber pacing for sinus node dysfunction. N Engl J Med 2002; 346:1854-1862.
14. Ricci R, Santini M, Puglisi A, Azzolini P, Capucci A, Pignalberi C, Boriani G, et al. Impact of consistent atrial pacing algorithm on premature atrial complexe number and paroxysmal atrial fibrillation recurrences in brady-tachy syndrome: A randomized prospective cross over study. J Interv Card Electrophysiol 2001; 5:33-44.
15. D'Allonnes GR, Pavin D, Leclercq C, Ecke JE, Jauvert G, Mabo P, Daubert JC. Long-term effects of biatrial synchronous pacing to prevent drug-refractory atrial tachyarrhythmia: A nine-year experience. J Cardiovasc Electrophysiol 2000; 11:1081-1091.
16. Saksena S, Prakash A, Ziegler P, Hummel JD, Friedman P, Plumb VJ, Wyse DG, et al. for DAPPAF Investigators. Improved suppression of recurrent atrial fibrillation with dual-site right atrial pacing and antiarrhythmic drug therapy. J Am Coll Cardiol 2002; 40:1140-1150.
17. Padeletti L, Pieragnoli P, Ciapetti C, Colella A, Musilli N, Porciani MC, Ricci R, et al. Randomized crossover comparison of right atrial appendage pacing versus interatrial septum pacing for prevention of paroxysmal atrial fibrillation in patients with sinus bradycardia. Am Heart J 2001; 142:1047-1055.
18. Bailin SJ, Adler S, Giudici M. Prevention of chronic atrial fibrillation by pacing in the region of Bachmann's bundle: Results of a multicenter randomized trial. J Cardiovasc Electrophysiol 2001; 12:912-917.
19. Friedman PA, Dijkman B, Warman EN, Xia HA, Mehra R, Stanton MS, Hammill SC, for the Worldwide Jewel AF Investigators. Atrial therapies reduce atrial arrhythmia burden in defibrillator patients. Circulation. 2001; 104:1023-1028.
20. Ricci R, Pignalberi C, Disertori M, Capucci A, Padeletti L, Botto G, Boriani G, et al. Antitachycardia pacing therapy to treat spontaneous atrial tachyarrhythmias: The 7250 Dual Defibrillator Italian Registry. Eur Heart J 2001; 3(Suppl. P):P25-P32.
21. Wellens HJJ, Lau CP, Luderitz B, Akhtar M, Waldo AL, Camm AJ, Timmermans C, et al. Atrioverter: An implantable device for the treatment of atrial fibrillation. Circulation 1998; 98:1651-1656.
22. Gold MR, Sulke N, Schwartzman DS, Mehra R, Euler DE, for the Worldwide Jewel AF-Only Investigators. Clinical experience with a dual chamber implantable cardioverter defibrillator to treat atrial tachyarrhythmias. J Cardiovasc Electrophysiol 2001; 12:1247-1253.
23. Jais P, Shah DC, Takahashi A, Hocini M, Haissaguerre M, Clementy J. Long-term follow-up after right atrial radiofrequency catheter treatment of paroxysmal atrial fibrillation. Pacing Clin Electrophysiol 1998; 21:2533-2538.
24. Pappone C, Oreto G, Lamberti F, Vicedomini G. Loricchio ML, Shpun S, Rillo M, et al. Catheter ablation of paroxysmal atrial fibrillation using a 3D mapping system. Circulation 1999; 100:1203-1208.
25. Haissaguerre M, Jais P, Shah DC, Garrigue S, Takahashi A, Lavergne T, Hocini M, et al. Electrophysiological end point for catheter ablation of atrial fibrillation initiated from multiple pulmonary venous foci. Circulation 2000; 101:1409-1417.
26. Tanigawa M, Fukatani M, Konoe A, Isomoto S, Kadena M, Hashiba K. Prolonged and fractionated atrial electrograms during sinus rhythm in patients with paroxismal atrial fibrillation and sick sinus node syndrome. J Am Coll Cardiol 1991; 17:403-408.
27. Centurion OA, Fukatani M, Konoe A, Tanigawa M, Shimizu A, Isomoto S, Kaibara M, et al. Different distribution of abnormal endocardial electrogramswithin the right atrium in patients with sick sinus syndrome. Br Heart J 1992; 68:596-600.
28. De Sisti A, Leclercq JF, Fiorello P, Manot S, Halimi F, Attuel P. Electrophysiologic characteristics of the atrium in sinus node dysfunction: Atrial refractoriness and conduction. J Cardiovasc Electrophysiol 2000; 11:30-33.
29. De Sisti A, Attuel P, Manot S, Fiorello P, Halimi F, Leclercq JF. Electrophysiological determinants of atrial fibrillation in sinus node dysfunction despite atrial pacing. Europace 2000; 2:304-311.
30. Stabile G, Senatore G, De Simone A, Turco P, Coltorti F, Nocerino P, Vitale DF, et al. Determinants of efficacy of atrial pacing in preventing atrial fibrillation recurrences. J Cardiovasc Electrophysiol 1999; 10:2-9.
31. Defaye P, Dournaux F, Mouton E, for the AIDA Multicenter Study Group. Prevalence of supraventricular arrhythmias from the automated analysis of data stored in the DDD pacemakers of 617 patients: The AIDA study. Pacing Clin Electrophysiol 1998; 21:250-255.
32. Andersen HR, Nielsen JC. Pacing in sick sinus syndrome. Need for a prospective, randomized trial comparing atrial with dual chamber pacing. Pacing Clin Electrophysiol 1998; 21:1175-1179.
33. Garrigue S, Barold S, Cazeau S, Gencel L, Jais P, Haissaguerre M, Clementy J. Prevention of atrial arrhythmias during DDD pacing by atrial overdrive. Pacing Clin Electrophysiol 1998; 21:1751-1759.
34. Camm J. AF therapy study: Preventive pacing for paroxysmal atrial fibrillation (abstract). Pacing Clin Electrophysiol 2002; 25:554.
35. Ricci R, Pignalberi C, Disertori M, Capucci A, Padeletti L, Botto G, Toscano S, et al. Efficacy of a dual chamber defibrillator with atrial antitachycardia functions in treating spontaneous atrial tachyarrhythmias in patients with life-threatening ventricular tachyarrhythmias. Eur Heart J 2002; 23:1471-1479.
36. Israel CW, Hugl B, Unterberg C, Lawo T, Kennis I, Hettrick D, Hohnloser SH, for the AT500 Verification Study Investigators. Pace-termination and pacing for prevention of atrial tachyarrhythmias: Results from a multicenter study with an implantable device for atrial therapy. J Cardiovasc Electrophysiol 2001; 12:1121-1128.
37. Gillis AM, Unterberg-Buchwald C, Schmidinger H, Massimo S, Wolfe K, Kavaney DJ, Otterness MF, et al. Safety and efficacy of advanced atrial pacing therapies for atrial tachyarrhythmias in patients with a new implantable dual chamber cardioverter-defibrillator. J Am Coll Cardiol 2002; 40:1653-1659.
38. Israel CW, Ehrlich JR, Gronefeld G, Klesius A, Lawo T, Lemke B, Hohnloser SH. Prevalence, characteristics and clinical implications of regular atrial tachyarrhythmias in patients with atrial fibrillation: Insights from a study using a new implantable device. J Am Coll Cardiol 2001; 38:355-363.
39. Adler SW, Wolpert C, Warman EN, Musley SK, Koehler JL, Euler DE, for the Worldwide Jewel AF Investigators. Efficacy of pacing therapies for treating atrial tachyarrhythmias in patients with ventricular arrhythmias receiving a dual-chamber implantable cardioverter defibrillator. Circulation. 2001; 104:887-892.
40. Wijffels MCEF, Kirchhof CJHJ, Dorland RD, Allessie MA. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 1995; 92:1954-1968.
41. Timmermans C, Levy S, Ayers GM, Jung W, Jordaens L, Rosenqvist M, Thibault B, et al. for the Metrix Investigators. Spontaneous episodes of atrial fibrillation after implantation of the Metrix atrioverter: Observations on treated and nontreated episodes. J Am Coll Cardiol 2000; 35:1428-1433.
42. Tse HF, Lau CP, Yu CM, Lee KL, Michaud GF, Knight BP, Morady F, et al. Effect of the implantable atrial defibrillator on the natural history of atrial fibrillation. J Cardiovasc Electrophysiol 1999; 10:1200-1209.